http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020084212-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0491 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 |
filingDate | 2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20020084212-A |
titleOfInvention | Drugs for the diagnosis of tissue reproductive activity or the treatment of proliferative diseases |
abstract | A pharmaceutical comprising a radiolabeled compound represented by the following general formula or a pharmaceutically acceptable salt thereof as an active ingredient.n n n n n n n n (Wherein R 1 represents hydrogen or a straight or branched chain alkyl group having 1 to 8 carbon atoms, R 2 represents hydrogen, hydroxy or halogen substituent, R 3 represents hydrogen or fluorine substituent, R 4 represents oxygen, sulfur or Methylene substituent and R 5 represents a radioactive halogen substituent.)n n n Since the drug is stable in vivo, stays in cells or incorporated into DNA, it is used for diagnosis of tissue proliferation or treatment of proliferative diseases. |
priorityDate | 2001-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 649.